160 related articles for article (PubMed ID: 18583935)
61. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
Karaiskou A; Perez LH; Ferby I; Ozon R; Jessus C; Nebreda AR
J Biol Chem; 2001 Sep; 276(38):36028-34. PubMed ID: 11461916
[TBL] [Abstract][Full Text] [Related]
62. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.
García-Gutiérrez L; Bretones G; Molina E; Arechaga I; Symonds C; Acosta JC; Blanco R; Fernández A; Alonso L; Sicinski P; Barbacid M; Santamaría D; León J
Sci Rep; 2019 Dec; 9(1):18693. PubMed ID: 31822694
[TBL] [Abstract][Full Text] [Related]
63. Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions.
Glab N; Labidi B; Qin LX; Trehin C; Bergounioux C; Meijer L
FEBS Lett; 1994 Oct; 353(2):207-11. PubMed ID: 7523194
[TBL] [Abstract][Full Text] [Related]
64. Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity.
Izumi T; Maller JL
Mol Biol Cell; 1995 Feb; 6(2):215-26. PubMed ID: 7787247
[TBL] [Abstract][Full Text] [Related]
65. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles.
Arris CE; Boyle FT; Calvert AH; Curtin NJ; Endicott JA; Garman EF; Gibson AE; Golding BT; Grant S; Griffin RJ; Jewsbury P; Johnson LN; Lawrie AM; Newell DR; Noble ME; Sausville EA; Schultz R; Yu W
J Med Chem; 2000 Jul; 43(15):2797-804. PubMed ID: 10956187
[TBL] [Abstract][Full Text] [Related]
66. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.
Chow JP; Siu WY; Ho HT; Ma KH; Ho CC; Poon RY
J Biol Chem; 2003 Oct; 278(42):40815-28. PubMed ID: 12912980
[TBL] [Abstract][Full Text] [Related]
67. Association of cyclin A and cdk2 with SV40 DNA in replication initiation complexes is cell cycle dependent.
Cannella D; Roberts JM; Fotedar R
Chromosoma; 1997 Apr; 105(6):349-59. PubMed ID: 9087377
[TBL] [Abstract][Full Text] [Related]
68. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
69. An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells.
Hochegger H; Dejsuphong D; Sonoda E; Saberi A; Rajendra E; Kirk J; Hunt T; Takeda S
J Cell Biol; 2007 Jul; 178(2):257-68. PubMed ID: 17635936
[TBL] [Abstract][Full Text] [Related]
70. CDK redundancy guarantees cell cycle progression in Rb-negative tumor cells independently of their p16 status.
Santamariña M; Hernández G; Zalvide J
Cell Cycle; 2008 Jul; 7(13):1962-72. PubMed ID: 18604173
[TBL] [Abstract][Full Text] [Related]
71. Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.
Lesuisse D; Dutruc-Rosset G; Tiraboschi G; Dreyer MK; Maignan S; Chevalier A; Halley F; Bertrand P; Burgevin MC; Quarteronet D; Rooney T
Bioorg Med Chem Lett; 2010 Mar; 20(6):1985-9. PubMed ID: 20167481
[TBL] [Abstract][Full Text] [Related]
72. Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach.
Tripathi SK; Singh SK; Singh P; Chellaperumal P; Reddy KK; Selvaraj C
J Mol Recognit; 2012 Oct; 25(10):504-12. PubMed ID: 22996593
[TBL] [Abstract][Full Text] [Related]
73. Requirement of Cyclin/Cdk2 and protein phosphatase 1 activity for chromatin assembly factor 1-dependent chromatin assembly during DNA synthesis.
Keller C; Krude T
J Biol Chem; 2000 Nov; 275(45):35512-21. PubMed ID: 10938080
[TBL] [Abstract][Full Text] [Related]
74. WEE1 kinase limits CDK activities to safeguard DNA replication and mitotic entry.
Elbæk CR; Petrosius V; Sørensen CS
Mutat Res; 2020; 819-820():111694. PubMed ID: 32120135
[TBL] [Abstract][Full Text] [Related]
75. Role for non-proteolytic control of M-phase-promoting factor activity at M-phase exit.
D'Angiolella V; Palazzo L; Santarpia C; Costanzo V; Grieco D
PLoS One; 2007 Feb; 2(2):e247. PubMed ID: 17327911
[TBL] [Abstract][Full Text] [Related]
76. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.
Risal S; Adhikari D; Liu K
Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715
[TBL] [Abstract][Full Text] [Related]
77. Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Expert Opin Investig Drugs; 2006 Jan; 15(1):23-38. PubMed ID: 16370931
[TBL] [Abstract][Full Text] [Related]
78. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
Ruiz EJ; Hunt T; Nebreda AR
Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
[TBL] [Abstract][Full Text] [Related]
79. Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.
Sugatani J; Osabe M; Kurosawa M; Kitamura N; Ikari A; Miwa M
Drug Metab Dispos; 2010 Jan; 38(1):177-86. PubMed ID: 19797611
[TBL] [Abstract][Full Text] [Related]
80. Transcription factor E2F and cyclin E-Cdk2 complex cooperate to induce chromosomal DNA replication in Xenopus oocytes.
Akamatsu E; Tanaka T; Kato JY
J Biol Chem; 1998 Jun; 273(26):16494-500. PubMed ID: 9632717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
